当前位置：首页 > 文献互助 > 互助详情

Single-molecule peptide sequencing through reverse translation of peptides into DNA复制

用户kzym4nX5XPFE 1小时前 45 10 求助中 帖子自动结束时间: 2026-03-30 18:05:08

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

L Zheng, Y Sun, LA Hein, M Eisenstein, HT Soh
Nature Biotechnology, 2026
nature.com
Despite advances in mass spectrometry and emerging single-molecule approaches, sequencing peptides at the single-molecule level remains a central challenge in proteomics. Here we present a

上一篇：Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia

下一篇：Characterisation of MRGPRX2+ mast cells in irritable bowel syndrome

互助时间线

2026-03-25 18:05:08 [发起求助]

最新发布的求助

Dilute alloy electrocatalysts enable asymmetric C–C coupling for ethylene production from a CO2 post-capture liquid 24分钟前
Syringin attenuates fibrogenesis and inflammation through SIRT3-regulated P2X7 receptor signaling pathway in hepatic fibrosis 47分钟前
Identification of KMH-45, a novel MRGPRX2 inhibitor with enhanced anti-pruritic properties 1小时前
Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease 1小时前
Introducing oxygen vacancies to NiFe LDH through electrochemical reduction to promote the oxygen evolution reaction 1小时前
Demonstrating the source of inherent instability in NiFe LDH-based OER electrocatalysts 1小时前
https://doi.org/10.1016/j.phymed.2025.157461 1小时前
In silico design of novel probes for the atypical opioid receptor MRGPRX2 1小时前
Characterisation of MRGPRX2+ mast cells in irritable bowel syndrome 1小时前
Single-molecule peptide sequencing through reverse translation of peptides into DNA 1小时前
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia 2小时前
黄连素熊脱氧胆酸盐用于2型糖尿病治疗：一项随机临床试验 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com